Multiple SkleroseManagement & ScienceeHealth

2023

Schlieter H, Susky M, Richter P, Hickmann E, Scheplitz T, Burwitz B, Ziemssen T.

HMD 59, 1545–1563 (2022).

Multiple SkleroseMS Behandlung

2023

Jiang T, Ziemssen T, Wray S, Shen C, Söderbärg K, Lewin JB, Božin I, Freedman MS.

CNS Drugs. 2023 May;37(5):441-452.

Multiple SkleroseNeuroimmunologie

2023

Sotirchos ES, Hu C, Smith MD, Lord HN, DuVal AL, Arrambide G, Montalban X, Akgün K, Ziemssen T, Naismith RT, Hersh CM, Hyland M, Krupp LB, Nicholas JA, Bermel RA, Mowry EM, Calabresi PA, Fitzgerald KC.

Neurology. 2023 Oct 10:10.1212/WNL.0000000000207957.

Multiple SkleroseMS BehandlungNeuroimmunologie

2023

Proschmann U, Mueller-Enz M, Woopen C, Katoul Al Rahbani G, Haase R, Dillenseger A, Dunsche M, Atta Y, Ziemssen T, Akgün K.

Mult Scler. 2023 Sep 30:13524585231200719.

Multiple SkleroseeHealth

2023

Inojosa H, Gilbert S, Kather JN, Proschmann U, Akgün K, Ziemssen T.

Neurol Res Pract. 2023 Aug 31;5(1):48.

Multiple SkleroseMS Behandlung

2023

Pinarello C, Elmers J, Inojosa H, Beste C, Ziemssen T.

Front. Neurosci. 2023 17:1231321.

Multiple SkleroseNeuroimmunologieAndere

2023

Wilson D, Chan D, Chang L, Mathis R, Verberk I, Montalban X, Comabella M, Fissolo N, Bielekova B, Masvekar R, Chitnis T, Ziemssen T, Akgün K, Blennow K, Zetterberg H, Brück W, Giovannoni G, Gnanapavan S, Bittner S, Zipp F, Comi G, Furlan R, Lehmann S, Thebault S, Freedman M, Bar-Or A, Kramer M, Otto M, Halbgebauer S, Hrusovsky K, Plavina T, Khalil M, Piehl F, Wiendl H, Kappos L, Maceski A, Willemse E, Leppert D, Teunissen C, Kuhle J.

Clin Chem Lab Med. 2023 Sep 13.

Multiple SkleroseNeuroimmunologie

2023

Woopen C, Dunsche M, Al Rahbani GK, Dillenseger A, Atta Y, Haase R, Raposo C, Pedotti R, Ziemssen T, Akgün K.

Vaccines (Basel). 2023 Sep 7;11(9):1464.